INTRODUCTION
Sphingolipids serve as constituents of membrane bilayers (1) and have emerged as potent signaling metabolites (2) (3) (4) (5) . Sphingolipid synthesis in eukaryotes begins with the condensation of serine and palmitoyl-CoA, a reaction catalyzed by the Lcb1p/Lcb2p serine palmitoyltransferase subunits ( Fig. 1) (6) (7) (8) (9) (10) . Ceramide serves as the backbone for all complex sphingolipids, and its biosynthesis is the point where animal and fungal sphingolipid biosynthesis begin to diverge (11) . In higher eukaryotes, there are over three hundred different types of complex sphingolipids found in membranes (1) , while in the yeast S. cerevisiae there are three, inositolphosphorylceramide (IPC 1 ),
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Like higher eukaryotes, yeast can esterify sterol through the activities of the endoplasmic reticulum-associated Are1p and Are2p ASAT enzymes (24) , with subsequent transport of sterol esters to lipid bodies (25) . However, sterol esterification in yeast is not essential, as are1 are2 double mutants are viable (24) . Recently, Tinkelenberg et al., (26) isolated yeast ARV1 in a synthetic lethal screen looking for genes that are essential in the absence of sterol esterification. Thus, ARV1 function is essential when yeast are unable to esterify sterol. Work from these same investigators suggested that arv1 cells have defects in sterol homeostasis and altered intracellular sterol distribution (26) . It was proposed that Arv1p was involved in sterol trafficking in yeast. Interestingly, ARV1 orthologs have been found in humans, worm, and plants, suggesting a possible conservation of function within these different gene products.
We recently isolated the ts erg26-1 strain in a genetic screen that was designed to isolate yeast mutants defective in sphingolipid metabolism, (27) . ERG26 encodes for 4α-carboxysterol-C3
dehydrogenase, one of the three enzyme activities that are required for the conversion of 4,4 dimethylzymosterol to zymosterol (28) (29) (30) . We showed that erg26-1 cells had sphingolipid metabolic defects and that blocking sterol biosynthesis in S. cerevisiae caused changes in sphingolipid metabolism (31) . These results further substantiate that yeast have mechanisms that are designed to coordinately regulate sphingolipid metabolism in response to changes in sterol levels. Interestingly, mutations in ARV1 were isolated in the same genetic screen. Thus, we explored the possibility that genes known to be required for the regulation of intracellular sterol homeostasis might regulate sphingolipid levels. Here, we present our data regarding the role of the ARV1 gene in regulating sphingolipid biosynthesis and metabolism. Yeast strains were grown in either YEPD (1% yeast extract, 2% bacto-peptone, 2% glucose) or in synthetic minimal media containing 0.67% Yeast Nitrogen Base (Difco) supplemented with the appropriate amino acids, and adenine. Yeast transformations were performed using the procedure described by Ito (32) . For routine propagation of plasmids, E. coli XL1Blue cells were used and grown in LB medium supplemented with ampicillin (200 µg/ml).
Strain Construction and Plasmids -Yeast null mutants were generated by the one-step disruption method of Rothstein (33) using the KanMX cassette (34). phARV1 was used for the overexpression studies of human ARV1 (26) . The plasmids pCB74-GFP-ARV1, pCB74-GFP-SEC21, and pCB74-GFP-YPT1, were constructed by subcloning ARV1, SEC21, and YPT1, into the vector pCB74, respectively. pCB74 allows for the construction of an amino-terminal GFP fusion and contains the GFP sequence under the constitutive GPD promoter (35) . The plasmid pGAL-GFP-SUR4
contains the SUR4 sequence subcloned as an amino terminal fusion with the GFP sequence.
Expression of GFP-Sur4p is galactose-inducible and is driven by the GAL4 promoter sequence.
Sequences subcloned into vectors were obtained by PCR amplification using the high fidelity pfu polymerase. All DNA sequences generated by PCR were sequenced and compared to the yeast genome database.
Metabolic Radiolabeling and Analysis of Lipids -Starting cultures for all lipid radiolabeling
experiments were grown overnight at 27˚C to exponential phase in synthetic complete media or selective minimal media. OD 600 were then taken and cultures were diluted to 5x10 6 cells/ml and pre- (38) and analyzed by one-dimensional TLC as described previously (39) .
Neutral lipid radiolabeling and TLC analysis was performed as described previously (39) . The rates of biosynthesis and steady state levels of neutral lipids were determined by densitometry. GC/MS Analysis of Sterols -Cells were grown under the conditions used for fatty acid analysis.
Sterols were extracted as part of the nonsaponifiable fraction essentially as described (41) . Washed cells were resuspended in 1.5 ml methanol, 1.0 ml 60% potassium hydroxide, 1.0 ml 0.5% pyrogallol and heated for 2 hours at 85°C. The nonsaponified material was extracted two times with petroleum ether, hexane (1:1). Cholesterol (20 µl of 0.5 mg/ml stock) was added to each sample for use as an Furthermore, sphingolipid biosynthetic defects in arv1 cells were observed at both the permissive and restrictive growth temperatures ( Fig. 2 , pulse; 27˚ vs. 37˚C).
We were unable to determine definitively what sphingolipid species corresponded to a particular TLC spot in arv1 cells using direct visual analysis. We circumvented this problem by analyzing the sphingolipid composition of the combinatorial strains, arv1 sur2 , arv1 scs7 , arv1 ccc2 , arv1 csg2 , and arv1 ipt1 , by TLC (not shown), and comparing these results to what we observed for arv1 cells.
We found that at the permissive temperature, arv1 cells synthesized very low levels of IPC-B and IPC-D when compared to wild type cells (Fig.2 pulse; 27 o C). The biosynthetic rates of these IPC species were 8.0-and 6.4-fold lower, respectively. The defect in IPC-C biosynthesis was even more severe, as we could not detect any biosynthesis of this sphingolipid in arv1 cells within the time of our assay ( Fig. 2 function to regulate sphingolipid biosynthesis and metabolism, we determined the rates of biosynthesis and steady-state levels of the various ceramides in arv1 and wild type cells using [ 3 H]dihydrosphingosine radiolabeling and TLC (37) .
Interestingly, we found that the rates of biosynthesis of all the major ceramides in arv1 cells were similar to those seen in wild type cells when assayed at either the permissive or restrictive temperature ( Fig. 3A & 3B ). In addition, arv1 cells were also able to sustain normal steady-state levels of dihydrosphingosine-derived ceramides, ceramide-A and ceramide-B' (Fig. 3C ). On the other hand, arv1 cells accumulated the phytosphingosine-derived ceramide-B and ceramide-C at both the permissive and restrictive growth temperatures ( Fig. 3C & 3D ). Ceramide-B and -C steady-state levels in arv1 cells were 285% and 198% higher than that seen in wild type cells, respectively ( Fig. 3C &   3D ).
We reasoned that ceramide accumulation in arv1 cells might be caused by decreases in the activities of either the Aur1p inositolphosphorylceramide synthase enzyme (48) or Ypc1p (49) and Ydc1p (50) ceramidase enzymes, since arv1 cells showed normal rates of biosynthesis of all ceramides. This is not the case, however, since the specific activities of these enzymes in cell extracts from arv1 and wild type cells were similar when assayed at both temperatures (not shown). where ARV1 function is required for viability, changes were evident in the rates of biosynthesis of PE, PS, and PG in arv1 cells (Fig. 4B) . The rates of biosynthesis of PE and PS in mutant cells were reduced 1.5-and 2.1-fold, respectively, while PG biosynthesis was increased 2.4-fold. The rates of 12 biosynthesis of PC, PI, PA, and CL were similar to that seen in wild type cells. Thus, ARV1 function is required for proper phospholipid biosynthesis at elevated temperatures.
Phospholipid Biosynthesis and Metabolism is Affected in arv1 Cells
Our results indicated that ARV1 function is not necessary for the biosynthesis of phospholipid under conditions where its function is dispensable for growth (Fig. 4A) . However, our phospholipid metabolic studies suggest a non-essential function for ARV1 in maintaining proper turnover and metabolism of phospholipid. We examined the steady-state levels of phospholipid in arv1 cells grown at the permissive temperature. Mutant cells contained lower levels of PE (1.3-fold) and PS (1.6-fold), while sustaining higher levels of PC (1.5-fold) and PG (1.3-fold) (Fig. 4C) . PI, PA and CL steady-state levels were similar to that seen in wild type cells. Furthermore, the steady-state levels of phospholipid in arv1 cells grown at the restrictive temperature were also altered, as PS levels (2.2-fold) decreased further, while PG levels (1.8-fold) accumulated to a greater extent in mutant cells (Fig.   4D ). The steady-state levels of PC, PE, PI, PA, and CL at the restrictive temperature were similar to those seen in wild type cells. Our radiolabeling studies and TLC method do not allow us to determine the rate of biosynthesis or metabolism of the branch-point phospholipid CDP-DG (51). Thus, we can not say whether or not ARV1k function is or is not required for proper biosynthesis and/or metabolism of CDP-DG.
Neutral Lipid and Fatty Acid Metabolism is Altered in arv1 Cells -The work of Tinkelenberg
et. al., (26) suggests that arv1 cells accumulate higher than normal steady-state levels of free sterol and sterol ester. To begin to understand the mechanism by which this occurs, we first determined the rates of biosynthesis of ergosterol and sterol ester, as well as the biosynthetic rates of several other neutral lipid species in arv1 cells.
Wild type and arv1 cells were pulse and steady state radiolabeled with [ 14 C]acetate and neutral lipids were resolved using TLC (30) . Using this method, we found that the rate of ergosterol biosynthesis in arv1 cells was similar to that seen in wild type cells, whether we assayed at the permissive or at restrictive growth temperature (Fig. 5A & 5B) . On the other hand, sterol ester biosynthesis was increased in arv1 cells at both temperatures (Fig. 5A & 5B) . Sterol ester production increased 1.7-and 2.1-fold over that seen in wild type cells at the permissive and restrictive temperatures, respectively. In addition, we detected decreases in the biosynthesis of total fatty acid and fatty acid alcohols in arv1 cells at both temperatures (Fig. 5A & 5B) . The rates of biosynthesis of mono-, di-, and triglycerides in arv1 cells at either temperature were similar to those rates seen in wild type cells.
The decrease in total fatty acid biosynthesis we detected in arv1 cells may be a consequence of the increased production of sterol ester. To define on a molecular level how fatty acid metabolism is altered in arv1 cells, we determined the metabolic levels of individual fatty acid species using GC/MS analysis. arv1 cells contained lower than wild type metabolic levels of C18:1 fatty acid and slightly higher levels of C16:0 (Fig. 6A ). These differences were seen at both temperatures. The metabolic levels of C16:1 and C18:0 in arv1 cells at either temperature were comparable to wild type levels. The metabolic levels of several minor fatty acid species were also altered in arv1 cells. arv1 cells accumulated C10:0, C12:0, and C26:0 fatty acids at either growth temperature (Fig. 6B) . The most dramatic increase was seen in the metabolic levels of C12:0 fatty acid in temperature-shifted arv1 cells (2.8-fold).
ARV1 Function is required for Sterol Metabolism -We next used GC/MS analysis to determine
the metabolic levels of individual sterols in wild type and arv1 cells grown at the permissive and restrictive growth temperatures. We observed differences in the levels of several sterols in arv1 cells when compared to wild type cells. First, we found that mutant cells grown at either temperature accumulated lower than wild type levels of ergosterol ( Fig. 7A & 7B) . In wild type cells grown at the permissive growth temperature, ergosterol accounted for approximately 70% of the total sterol, whereas it accounted for only 58% of the total sterol in arv1 cells (Fig. 7A) . A similar fold reduction in ergosterol levels was seen at the restrictive growth temperature in arv1 cells (Fig. 7B) .
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Second, arv1 cells had higher than wild type levels of lanosterol and lower levels of zymosterol at either temperature ( Fig. 7A & 7B) . The greatest accumulation of lanosterol occurred at the restrictive growth temperature, where arv1 cells had 3.1-fold higher levels than wild type cells (Fig. 7B) . Third, arv1 cells did not accumulate any measurable amount of episterol at the permissive temperature (Fig. 7A) . At this temperature, episterol accounted for 2.3% of the total sterol in wild type cells. Finally, arv1 cells accumulated higher than wild type levels of several unknown sterol intermediates that were grouped together in our analysis (Fig. 7A & 7B, other) . These intermediates accumulated at either temperature analyzed. At the permissive temperature, they made up approximately 17% of the total sterol in arv1 cells, and accumulated 3.4-fold higher in mutant cells (Fig. 7A) . At the restrictive growth temperature, they accumulated 2.1-fold higher in mutant cells, and made up 15.5% of the total sterol (Fig. 7B ).
Arv1p Resides within Multiple Organelles in Yeast -To begin to elucidate the molecular
function of Arv1p, we determined its intracellular location using fluorescence microscopy. Arv1p was GFP-tagged at the amino terminus and expressed under the constitutive GPD promoter using the plasmid, pCB74-GFP-ARV1. In this context, GFP-Arv1p was functional, as pCB-GFP-ARV1
complemented the ts phenotype of arv1 cells (not shown). Although, we can not rule out that the overexpression of GFP-Arv1p from this construct does not result in partial mislocalization. GFPArv1p localized to both the ER and golgi (Fig. 8) . Localization patterns for GFP-Arv1p were similar either to an ER-resident fatty acid elongase (Sur4p, (52), Fig. 8, ER) or to the golgi-associated COPI coatamer subunit, Sec21p (53) and Rab GTPase Ypt1p (54) (Fig. 8, Golgi) . The localization GFPArv1p in either the ER or golgi was somewhat bud size and/or growth phase dependent, suggesting a possible cell-cycle regulated localization.
Overexpression of the Human ARV1 Gene Suppresses the Lipid Metabolic Defects of arv1
Cells -arv1 cells are nystatin sensitive and are unable to grow either at elevated temperatures or under anaerobic conditions (26) . Tinkelenberg et al., (26) showed that these phenotypes could be shifted arv1 cells to levels that were only slightly lower then those seen in wild type cells (Fig. 9) ; growth in galactose media most likely accounts for the differences observed in sphingolipid profiles in It has been suggested that Arv1p functions in trafficking sterol in yeast (26) . We did show using GC/MS that arv1 cells had altered sterol levels and accumulated a class of uncharacterized sterol intermediates (Fig. 6 ). Sterol metabolic defects could arise from improper trafficking of sterol (22) . However, we also demonstrated that mutant cells had defects in their ability to properly synthesize and maintain sphingolipid, especially under conditions where Arv1p function was required for viability (Fig. 2) . Therefore, Arv1p may function to regulate sphingolipid metabolism, and the sterol defects we observe in arv1 cells could result from improper sphingolipid homeostasis. It is also possible that Arv1p has a dual function and regulates both sphingolipid and sterol metabolism and transport. This could explain why its loss results in metabolic defects in both sterol and sphingolipid.
If Arv1p functions only in trafficking sterol, how does its loss affect sphingolipid metabolism?
The proper trafficking of sterol may be necessary for efficient vesicular transport of sphingolipid pathway substrates to different organelles. Sphingolipid biosynthesis takes place both in the endoplasmic reticulum and in the golgi (25) . Hechtberger et al., (58) have found that vacuoles in yeast are enriched with IPCs. Complex sphingolipids are found in abundance in the plasma membrane (58) (59) (60) . In addition, LCB phosphatases have been localized to the ER (61). Thus, sphingolipid metabolites (substrates) are transported to multiple organelles.
arv1 cells accumulated phytosphingosine-derived ceramides (Fig. 2) . Thus, mutant cells have lost the ability to properly regulate ceramide metabolism. Therefore, Arv1p may be involved in the trafficking of ceramide to the intracellular location of the Aur1p inositolphosphorylceramide synthase (48, 62) . Aur1p has been localized to the golgi apparatus (63) . We found Arv1p in the ER and golgi in yeast cells (Fig. 9 ). Funato and Riezman, (64) using a cell-free transport assay, showed that ceramide is transported to the golgi using vesicle-dependent and -independent mechanisms in yeast. Thus,
Arv1p may function within one or both of these pathways in the ER to golgi transport of ceramide.
Since ceramide is synthesized in the ER of animal cells and is transported to the golgi for conversion to We showed that arv1 cells had lower levels of PE and PS, while accumulating PC and PG (Fig. 4) . Although we did not determine the levels of dihydro-and phytosphingosine, it is possible that these LCBs accumulate in arv1 cells due to a block in complex sphingolipid biosynthesis. PS synthase is inhibited by LCBs (18) . A decrease in PS synthase activity may in turn cause a reduction in PE levels in cells. Moreover, a reduction in PS levels, along with a decrease in complex sphingolipid synthesis, could cause an accumulation of the branchpoint lipid, CDP-DG. CDP-DG is a precursor for PG synthesis (51) . Excess CDP-DG may be shunted to PG metabolism to ensure that the levels of this lipid do not exceed those required to inhibit PI 4-kinase (70) 
